<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100891">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01993459</url>
  </required_header>
  <id_info>
    <org_study_id>14091991</org_study_id>
    <nct_id>NCT01993459</nct_id>
  </id_info>
  <brief_title>The Effects of Midazolam on the Quality of Postoperative Recovery</brief_title>
  <acronym>WOLII</acronym>
  <official_title>A Randomized Controlled Trial on the Effects of Midazolam on the Quality of Postoperative Recovery in Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasmus Medical Center</source>
  <oversight_info>
    <authority>Netherlands: Medical Ethics Review Committee (METC)</authority>
    <authority>Netherlands: Ministry of Health, Welfare and Sport</authority>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Midazolam given pre-operatively to
      patients undergoing abdominal surgery improves the quality of recovery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Quality of Recovery (QoR-40 Scale)</measure>
    <time_frame>baseline, workday 3 postoperative, workday 7 postoperative</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in anxiety measured with a Dutch translated State-Trait Anxiety Inventory (STAI)</measure>
    <time_frame>baseline, workday 1 postoperative, workday 7 postoperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in depressive moods and anxiety measured by a Dutch translation of the Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>baseline, workday 1 postoperative, workday 7 postoperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fatigue measured by a validated Dutch questionnaire Multidimensional Fatigue Index : &quot;Multidimensionele Vermoeidheids Index&quot; (MVI-20)</measure>
    <time_frame>baseline, workday 7 postoperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-efficacy measured by a Dutch translation of General Self-Efficacy- Schwarzer (GSES).</measure>
    <time_frame>baseline, workday 7 postoperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Systolic bloodpressure</measure>
    <time_frame>baseline, workday 1 postoperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-esteem measured by a Dutch translation of the and Rosenberg self-esteem scale (RSES)</measure>
    <time_frame>baseline, workday 7 postoperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Diastolic Blood pressure</measure>
    <time_frame>baseline, workday 1 postoperative</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Temperature after surgery measured with an ear thermometer</measure>
    <time_frame>directly after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Heart Rate</measure>
    <time_frame>preoperatively, during surgery and postoperatively</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Postoperative Period</condition>
  <condition>Anxiety</condition>
  <condition>Fatigue</condition>
  <condition>Depression</condition>
  <condition>Aggression</condition>
  <arm_group>
    <arm_group_label>Midazolam intravenous</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3mg/ml midazolam given intravenously</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NaCl (sodium chloride) 0,9%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>NaCl (sodium chloride) 0,9% given intravenously 3ml.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>We will administer Midazolam 3mg intravenously once pre-operatively to patients just before they undergo surgery</description>
    <arm_group_label>Midazolam intravenous</arm_group_label>
    <other_name>Dormicum</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NaCl (sodium chloride) 0,9%</intervention_name>
    <description>We will administer NaCl (sodium chloride) 0,9% 3ml intravenously once pre-operatively to patients just before they undergo surgery</description>
    <arm_group_label>NaCl (sodium chloride) 0,9%</arm_group_label>
    <other_name>saline solution</other_name>
    <other_name>sodium chloride solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patieÌˆnts operated with a laparotomy in the Erasmus Medical Center of Rotterdam,
             older than 18 years and planned for a postoperative stay for a minimum of 3 days

        Exclusion Criteria:

          -  Pregnant, benzodiazepine usage, contra-indication for midazolam, mental retardation,
             non-dutch speaking patients
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Jan Stolker, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Erasmus MC Rotterdam Anesthesiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Klimek, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Erasmus MC Rotterdam Anesthesiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefan van Beek, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasmus MC Rotterdam Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan van Beek, BSc</last_name>
    <phone>(+31)0640390422</phone>
    <email>s.vanbeek@erasmusmc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Markus Klimek, MD, PhD</last_name>
    <phone>010 - 703 3713</phone>
    <email>m.klimek@erasmusmc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erasmus Medical Centre</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid-Holland</state>
        <zip>3000CA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefan van Beek, BSc</last_name>
      <phone>+31 010 704 0 704</phone>
      <email>s.vanbeek@erasmusmc.nl</email>
    </contact>
    <investigator>
      <last_name>Stefan van Beek, BSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 20, 2013</lastchanged_date>
  <firstreceived_date>October 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasmus Medical Center</investigator_affiliation>
    <investigator_full_name>Stefan van Beek</investigator_full_name>
    <investigator_title>BSc</investigator_title>
  </responsible_party>
  <keyword>Quality of Recovery</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aggression</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
